Led by Dr Carol Howell, PhD.
Dr Carol A. Howell, PhD, is Research Director at Enteromed. Her academic career has focused on gastrointestinal health, with research published in BMJ Open Gastroenterology and GUT journal. She has spent over 15 years researching intestinal adsorbents and digestive function at the University of Brighton.
Enterosgel has been used in homes and clinics across Eastern Europe and Central Asia for over 40 years — long before it reached UK shelves. It's a drug-free gel that captures irritants in the gut and carries them through naturally.
When Enteromed launched the brand in the UK in 2016, the goal was straightforward — make this established product accessible to UK customers and clinicians.
In 2022, Enterosgel was added to the NHS Prescription Drug Tariff, recognising it as a regulated medical device available through GP prescriptions. Today, it's used in over 30 countries — and we're focused on giving UK customers honest, science-backed information about how it works.
Timeline
Four decades of research.
40+ Years
Enterosgel developed and used in clinical practice across Eastern Europe
2016
UK launch via Enteromed
2019
Published in BMJ Open Gastroenterology (Howell CA et al.)
2022
Added to NHS Prescription Drug Tariff
2024
Cited in The Lancet (Black & Ford, Lancet Gastroenterol Hepatol)
Ready to try it?
